Clinical Trials Logo
  1. Home
  2. Renal Transplantation
  3. NCT04863716
  4. Details
NCT04863716 Clinical Trial

Erector Spinae Plane Block in Renal Transplantation Donors

Renal Transplantation Clinical Trial

Official title:
Effects of Erector Spinae Plane Block on Opioid Consumption in Renal Transplantation Donors

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04863716
Other study ID # KocUniversityH
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 28, 2021
Est. completion date April 14, 2022

Study information
Verified date September 2022
Source Koc University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Erector Spina Plan Block (ESPB) is a relatively new, easy-to-apply and safe regional anesthesia technique used to provide postoperative analgesia in various surgeries. Studies showing the clinical benefits of Erector Spina Plan block in renal transplantation surgery are limited to case reports. In this study, the effect of Erector Spina Plan Block on opioid consumption in postoperative period on donor patients who will undergo laparoscopic nephrectomy in renal transplantation surgery will be examined prospectively. The aim of the study is to provide analgesia to donor patients using less opioids by Erector Spina Plan Block and provide enhanced recovery.

Recruitment information / eligibility
Status Completed
Enrollment 52
Est. completion date April 14, 2022
Est. primary completion date April 10, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Donor patients scheduled for elective nephrectomy in renal transplantation surgery - ASA I-II - Patients who are aged between 18-75 Exclusion Criteria: - Skin infection at the Erector Spina Plan Block area - Coagulation disorder or using anticoagulant drugs - End-stage organ and system failure - Severe pulmonary and/or cardiovascular problems - Substance addiction or known psychiatric or mental problems - Chronic painkiller usage

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Erector Spinae Plane Block
Erector Spinae Plane Block will be administered before the surgery.
• Intravenous fentanyl patient control device
24-hour fentanyl consumption will be recorded.

Locations
Country Name City State
Turkey Koç University Hospital Istanbul Zeytinburnu

Sponsors (1)
Lead Sponsor Collaborator
Koc University Hospital

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary Fentanyl consumption The amount of fentanyl required by the patient and given by the device will be recorded for the first 24 hours. Postoperative 24 hours
Secondary Visual Analog Scale Pain of patients will be evaluated and recorded according to the Visual Analog Scale. Postoperative 24 hours
Secondary Modified Aldrete Score Modified Aldrete Score will be used in patient recovery, and scores will be recorded at 5 minute intervals. Postoperative 1 hour
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06026592 - Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
Active, not recruiting NCT02444429 - 3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation Phase 3
Completed NCT02238418 - Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria. Phase 4
Completed NCT01729494 - Belatacept Early Steroid Withdrawal Trial Phase 4
Terminated NCT01436305 - Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation Phase 2
Terminated NCT01276834 - Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation Phase 4
Completed NCT02843295 - Catalytic Antibodies to Predict Uninvasively Late Transplant Failure N/A
Completed NCT00842699 - Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab N/A
Completed NCT00525681 - Interaction Between Rimonabant and Cyclosporine and Tacrolimus Phase 4
Completed NCT00189735 - A Study to Evaluate FK778 in Kidney Transplant Patients Phase 2
Completed NCT00776750 - Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients Phase 4
Recruiting NCT04052867 - Intravenous Lignocaine Infusion in Laparoscopic Donor Nephrectomy N/A
Recruiting NCT03114826 - Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients N/A
Completed NCT02587052 - A 1-year Comparison of Generic Tacrolimus (Tacni) and Prograf in Renal Transplant Patients - a Retrospective Matched Pair Analysis, GenTac
Completed NCT02020642 - Effect of Renal Transplantation on Obstructive Sleep Apnea in End Stage Renal Disease Patients (SASinTx) N/A
Completed NCT01435291 - AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation Phase 4
Recruiting NCT01001065 - Association of the Intrarenal Resistance Index (RI) of Transplanted Kidneys With Generalized Atherosclerosis N/A
Completed NCT00978965 - Identification of Patients With High Probability of Poorly Responding to Therapy With Mycophenolic Acid Prodrugs
Recruiting NCT00903188 - Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation Phase 4
Completed NCT00400400 - Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance Phase 4